Pharm-Olam is now Allucent. Learn More

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_ebook_updated-0723-FINAL-1
Adaptive Design Considerations for Early Phase Oncology Trials

“Adaptive designs” in clinical research refer to study designs where certain features are left flexible on purpose, so they can...


(6 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

The Role of Liquid Biopsies in the Clinical Trial Setting

A liquid biopsy is a testing technique where a sample of blood is analysed for cancer cells from a tumour that is circulating in...


(4 minute read)

Tags: Oncology-Hematology Disease

Cancer clinical trials: Recent oncology research studies in review

Oncology is a multi-faceted field of study and a popular one. Cancer clinical trials account for more than 19% of the research...


(4 minute read)

Tags: Oncology-Hematology Disease

Clinical Trials Today: Recent Milestones in Rare Cancer Research

Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer happened...


(4 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Conducting Clinical Trials in Rare Oncology

Rare oncology is a subset of Oncology that encompasses those cancers with the rarest incidence. They may be a common type like...


(4 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Phase I Oncology PD-1 Inhibitor Enrolled 78 Days Early

Pharm-Olam is a mid-sized, global CRO that provides clinical research solutions for rare diseases, oncology, hematology,...


(1 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

Effective Cohort Management in Early Phase Oncology Trials

Cohort management is part and parcel of conducting dose-escalation studies, but not all teams effectively manage it. Pharm-Olam...


(5 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover